Exelixis (EXEL) EBIT Margin Growth (3y) (2013 - 2026)
Exelixis (EXEL) EBIT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 828,504.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7,261.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -50,506.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -2,649.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 9,003.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 30,461.00 |
| 10 | Exelixis | 12.75 Bn | 11.91 Bn | 608.03 Mn | 2,294.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 2,294.00 |
| Apr 3, 2026 | 3,410.00 |
| Jan 2, 2026 | 5,063.00 |
| Oct 3, 2025 | 1,951.00 |
| Jul 4, 2025 | 1,763.00 |
| Apr 4, 2025 | 1,026.00 |
| Sep 27, 2024 | 950.00 |
| Jun 28, 2024 | 1,136.00 |
| Mar 29, 2024 | 863.00 |
| Dec 29, 2023 | 805.00 |
| Sep 29, 2023 | 1,470.00 |
| Jun 30, 2023 | -1,254.00 |
| Mar 31, 2023 | -1,622.00 |
| Dec 30, 2022 | -4,351.00 |
| Sep 30, 2022 | -2,248.00 |
| Jul 1, 2022 | -1,833.00 |
| Apr 1, 2022 | -1,586.00 |
| Oct 1, 2021 | -3,982.00 |
| Jul 2, 2021 | -1,415.00 |
| Apr 2, 2021 | -5,613.00 |